Mechanistically, SOX2 is necessary for maintaining GSC properties in GBM and medulloblastoma cells, but is not sufficient to support self-renewal properties (Alonso et al., 2011; Berezovsky et al., 2014) again highlighting a role for TFs in tumor progression but not tumor initiation. The gene discussed is SOX2; the disease is glioblastoma.